KYMERA THERAPEUTICS, INC. (KYMR) Total liabilities 2019–2025
KYMERA THERAPEUTICS, INC. (KYMR) total liabilities at each fiscal year-end, per SEC filings.
$163.1MFY2025 · since FY2019: $82.0M → $163.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $163.1M | +14.6% |
| FY2024 | $142.4M | -21.2% |
| FY2023 | $180.8M | +60.0% |
| FY2022 | $113.0M | -22.8% |
| FY2021 | $146.3M | -28.0% |
| FY2020 | $203.3M | +147.8% |
| FY2019 | $82.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice